The Orthopedic Implants Market sits at the intersection of demographic inevitability and relentless innovation. As ...

Tirzepatide and semaglutide are weight-loss drugs effective for managing both obesity and knee osteoarthritis, when combined ...

An age-old Indian tradition of eating while sitting on the floor offers surprising health advantages, particularly for joint ...

Knee osteoarthritis (OA) is a prevalent chronic, progressive, degenerative condition in older individuals, characterized by ...

Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass ...

Max Super Speciality Hospital, Saket, has set a global record in joint replacement surgery by discharging a patient just 18 ...

Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

Elena Losina, PhD, codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital, discusses the cost-effectiveness of varying weight loss interventions.

The global high tibial osteotomy plates market size was US$ 311.06 million in 2021. The global high tibial osteotomy plates market size is forecast to reach US$ 400.3 million by 2030, growing at a ...

Studies have found that it can improve gait and balance, reduce step length, and increase gait speed—all indicators of better ...

Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with knee osteoarthritis (OA) and obesity, according to a ...

A man who has suffered two strokes and has a pacemaker, osteoarthritis and one kidney, cycled from London to his home in ...